Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist

European Neuropsychopharmacology

Volumn 18, Issue 11, 2008, Pages 814-819

  Perera, Pin Yu ^a   Lichy, Jack H ^a   Mastropaolo, John ^a   Rosse, Richard B ^a   Deutsch, Stephen I ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Balb c mouse; MK 801; NMDA receptor; Schizophrenia

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PHENCYCLIDINE; SARCOSINE;

ALLOSTERISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BEHAVIOR; BRAIN CORTEX; DRUG SENSITIVITY; HIPPOCAMPUS; JUMPING; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; STRAIN DIFFERENCE; SWISS WEBSTER MOUSE; TONIC SEIZURE; WESTERN BLOTTING;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CEREBRAL CORTEX; DENSITOMETRY; DIZOCILPINE MALEATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MICE; MICE, INBRED BALB C; NERVE TISSUE PROTEINS; PHENCYCLIDINE; RECEPTORS, N-METHYL-D-ASPARTATE; SPECIES SPECIFICITY;

EID: 52949113398     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.06.004     Document Type: Article

References (12)

1. Danysz W., and Parsons C.G. Glycine and N-Methyl-D-Aspartate receptors: physiological significance and possible therapeutic applications. Pharmacological Reviews 50 (1998) 597-664
2. Deutsch S.I., Mastropaolo J., Schwartz B.L., Rosse R.B., and Morihisa J.M. A "glutamatergic hypothesis" of schizophrenia: rationale for pharmacotherapy with glycine. Clinical Neuropharmacology 12 1 (1989) 1-13
3. Deutsch S.I., Mastropaolo J., Riggs R.L., and Rosse R.B. The antiseizure efficacies of MK-801, phencyclidine, ketamine and memantine are altered selectively by stress. Pharmacology Biochemistry and Behavior 58 3 (1997) 709-712
4. Deutsch S.I., Rosse R.B., Paul S.M., Riggs R.L., and Mastropaolo J. Inbred mouse strains differ in sensitivity to popping elicited by MK-801. Pharmacology Biochemistry and Behavior 57 1/2 (1997) 315-317
5. Deutsch S.I., Mastropaolo J., Powell D.G., Rosse R.B., and Bachus S.E. Inbred mouse strains differ in their sensitivity to an antiseizure effect of MK-801. Clinical Neuropharmacology 21 4 (1998) 255-257
6. Deutsch S.I., Rosse R.B., Long K.D., Gaskins B., and Mastropaolo J. Rare neurodevelopmental abnormalities of sarcosinemia may involve glycinergic stimulation of a primed NMDA receptor. Clinical Neuropharmacology 29 (2006) 361-363
7. Durand G.M., Bennett M.V.L., and Zukin R.S. Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proceedings of the National Academy of Sciences of the United States of America 90 (1993) 6731-6735
8. Javitt D., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148 (1991) 1301-1308
9. Long K.D., Mastropaolo J., Rosse R.B., Manaye K.F., and Deutsch S.I. Modulatory effects of D-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain. Brain Research Bulletin 69 (2006) 626-630
10. Long K.D., Mastropaolo J., Rosse R.B., and Deutsch S.I. Exogenously administered D-serine failed to potentiate the ability of MK-801 to antagonize electrically precipitated seizures in nonhandled control and stressed mice. European Neuropsychopharmacology 17 1 (2007) 53-57
11. Millan M.J. N-methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179 (2005) 30-53
12. Schork N.J., Greenwood T.A., and Braff D.L. Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research. Schizophrenia Bulletin 33 1 (2007) 95-104